Abstract:Significance: Autophagy is a self-degrading process that determines cell fate in response to various environmental stresses. In contrast to autophagy-mediated cell survival, the signals, mechanisms, and effects of autophagy-dependent cell death remain obscure. The discovery of autophagy-dependent ferroptosis provides a paradigm for understanding the relationship between aberrant degradation pathways and excessive lipid peroxidation in driving regulated cell death. Recent Advances: Ferroptosis was originally described as an autophagy-independent and iron-mediated nonapoptotic cell death. Current studies reveal that the level of intracellular autophagy is positively correlated with ferroptosis sensitivity. Selective autophagic degradation of proteins (e.g., ferritin, SLC40A1, ARNTL, GPX4, and CDH2) or organelles (e.g., lipid droplets or mitochondria) promotes ferroptosis by inducing iron overload and/or lipid peroxidation. Several upstream autophagosome regulators (e.g., TMEM164), downstream autophagy receptors (e.g., HPCAL1), or danger signals (e.g., DCN) are selectively required for ferroptosis-related autophagy, but not for starvation-induced autophagy. The induction of autophagy-dependent ferroptosis is an effective approach to eliminate drug-resistant cancer cells. Critical Issues: How different organelles selectively activate autophagy to modulate ferroptosis sensitivity is not fully understood. Identifying direct protein effectors of ferroptotic cell death remains a challenge. Future Directions: Further understanding of the molecular mechanics and immune consequences of autophagy-dependent ferroptosis is critical for the development of precision antitumor therapies. Antioxid. Redox Signal. 39, 79-101.

System Xc−: a key regulatory target of ferroptosis in cancer

Targeting Ferroptosis in Breast Cancer

Targeting Ferroptosis for Cancer Therapy: Exploring Novel Strategies from Its Mechanisms and Role in Cancers

System Xc−/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy

Advances in ferroptosis of cancer therapy

Ferroptosis and Its Multifaceted Role in Cancer: Mechanisms and Therapeutic Approach

Ferroptosis and its emerging role in tumor

The Molecular Mechanisms of Regulating Oxidative Stress-Induced Ferroptosis and Therapeutic Strategy in Tumors

The crosstalk between oncogenic signaling and ferroptosis in cancer

Ferroptosis resistance in cancer: recent advances and future perspectives

Emerging mechanisms and targeted therapy of ferroptosis in cancer

Ferroptosis: Opportunities and Challenges in Cancer

The regulation and function of Nrf2 signaling in ferroptosis-activated cancer therapy

Understanding the mechanistic regulation of ferroptosis in cancer: the gene matters

Ferroptosis in life: To be or not to be

Advancing the frontiers of colorectal cancer treatment: harnessing ferroptosis regulation

Molecular mechanisms of ferroptosis and its role in cancer therapy

Xct: A Critical Molecule That Links Cancer Metabolism to Redox Signaling.

Autophagy-Dependent Ferroptosis in Cancer

Broadening horizons: the role of ferroptosis in cancer

Ferroptosis: principles and significance in health and disease